TrialJournal of clinical pharmacology2025

Exposure-Efficacy Analysis and Dopamine D2 Receptor Occupancy in Adults with Schizophrenia after Treatment with the Monthly Intramuscular Injectable Risperidone ISM.

Andreas Lindauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.